Dr. Rezk is a diabetologist who has spent more than 20 years in the pharmaceutical industry. Prior to joining Biogen as the Senior Director, Global Head of Medical Affairs for their biosimilars business unit, he was with Amgen as an international medical lead for the company’s nephrology innovator biologics and their EU biosimilars taskforce. While there, he established an internal biosimilars medical platform and led the development and execution of a significant number of multinational studies, key publications and poster presentations. Prior to Amgen, he was with Novo Nordisk Africa & Gulf as the region’s medical affairs director, establishing diabetes and hematology clinical and medical educational infrastructures supporting the launch of the company’s second-generation insulin analogues and hemophilia treatments. He also spent nearly 11 years with Johnson & Johnson Middle East where he was marketing and sales lead for the company’s biotechnology business unit, after which he moved to head the medical affairs team.